HomeAI · summaries
Storia in 11 fonti
New experimental Alzheimer's drug shows potential after study shows slower cognitive decline | Fortune
A study on Biogen's diranersen found it slowed cognitive decline and has promise in treating Alzheimer's disease, researchers found.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
biopharmadive.com
Biogen data highlight promise, questions surrounding tau-targeting Alzheimer’s drugs
The study provides the clearest evidence yet that medicines like BIIB080 might improve cognition, but leaves unclear why higher doses didn’t perform better.
- ·
apnews.com
An experimental Alzheimer's drug shows some promise as researchers hunt new approaches
An experimental drug might help slow early Alzheimer's disease in a markedly different way than current treatments — by lowering the brain's production of a protein called tau.
